摘要
目的研究门冬胰岛素30单用或联合其他降血糖药物治疗2型糖尿病时对患者血糖波动的影响。方法 94例2型糖尿病患者随机分为三组。A组31例,单用门冬胰岛素30,早晚餐前皮下注射,起始剂量0.4 U·kg-1·d-1。B组32例,门冬胰岛素30(用法同前)+瑞格列奈1.0 mg,po,tid。C组31例,门冬胰岛素30(用法同前)+阿卡波糖50 mg,po,tid。记录各组血糖达标时间及达标后日均胰岛素用量,采用全日7点血糖(三餐前、餐后2 h、晚上23:00)监测法来评价三组患者血糖波动情况,并观察低血糖发生情况。结果 A组达标时间长于B组和C组,达标后日均胰岛素用量高于其他两组,均有显著差异(P<0.05),B组和C组达标时间、达标后日均胰岛素用量均无显著差异(P>0.05)。三组治疗后全日7点血糖、平均血糖值、血糖标准差(SDBG)均降低(P<0.05)。A组中餐后血糖、血糖漂移值及SDBG高于B组和C组(P<0.05),B组高于C组(P<0.05)。C组早、晚餐后血糖漂移值低于A组和B组(P<0.05),A、B两组间无显著差异(P>0.05)。C组低血糖发生率10%,低于A组(39%)和B组(25%),差异显著(P<0.05),A、B两组间无显著差异(P>0.05)。结论三种治疗方案均能有效改善2型糖尿病患者血糖,门冬胰岛素30联合阿卡波糖在降低餐后血糖漂移、SDBG及低血糖发生率方面优于门冬胰岛素30单用及与瑞格列奈联用方案。
AIM To study the effects of insulin aspart 30 alone or combined with other hypoglycemic agents on the blood glucose fluctuation in type 2 diabetes patients. METHODS Ninety-four type 2 diabetes patients were randomly divided into three groups. Group A( n = 31) : insulin aspart 30 injection was administrated before breakfast and dinner, with the initial dose 0.4 U·kg-1·d-1; group B( n = 32) : insulin aspart 30 injection was used as group A, and together with repaglinide(1.0 mg, po, tid); group C(n = 31):insulin aspart 30 injection was used as group A, and together with acarbose( 50 mg, po, tid). The time to reach well-controlled blood glucose and daily insulin dosage were recorded. The 7 point(before meals, 2 hours after meals and 23: 00 p.m.) blood glucose monitoring method was used to evaluate the blood glucose fluctuations and the incidence of hypoglycemia was observed. RESULTS The time and daily insulin dose used to achieve well-controlled the blood glucose were significantly higher in the group A than those of the group B and group C( P 〈 0.05), while no significant difference between group B and group C( P 〉 0.05). After the treatment, the 7 point blood glucose throughout the day, mean and standard deviation of blood glucose(MBG and SDBG) of all three groups decreased significantly(P 〈 0.05). The blood glucose after lunch, fluctuation of postprandial blood glucose(PBG) after lunch and SDBG of group A were significantly higher than those of the group B and group C( P 〈 0.05), and those in the group B were higher than the group C( P 〈 0.05). The fluctuation of PBG after breakfast and dinner of the group C were lower than those of the group A and group B(P 〈 0.05), while no significant between group A and group B(P 〉 0.05). The incidence rate of hypoglycemia of the group C was 10%, which was significantly lower than that in the group A(39%) and B(25%, P 〈0.05), while no significant difference between group A and group B
出处
《中国新药与临床杂志》
CAS
CSCD
北大核心
2015年第5期386-389,共4页
Chinese Journal of New Drugs and Clinical Remedies
关键词
糖尿病
2型
门冬胰岛素
阿卡波糖
瑞格列奈
血糖波动
diabetes mellitus,type 2
insulin aspart
acarbose
repaglinide
blood glucose fluctuation